Approval · Notice of Compliance 3080 · 1998
REVIA: Notice of Compliance 3080
Issued August 21, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3080
- Date
- August 21, 1998
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Opioid antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVIA | 02213826 | Marketed |
Medicinal ingredients
- NALTREXONE HYDROCHLORIDE 50 MG per TAB